Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-029126
Date:2021-04-28
Issuer: ATYR PHARMA INC (LIFE)
Original Submission Date:

Reporting Person:

SCHIMMEL PAUL
3545 JOHN HOPKINS COURT, SUITE #250
SAN DIEGO, CA 92121

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 4.21 2021-04-28 deemed execution date A 1,428 (a) 2031-04-28 common stock 1,428 $4.21 1,428 direct
Footnotes
IDfootnote
f1 the option, granted pursuant to the issuer's non-employee director compensation policy, vests in full on the earlier of (i) april 28, 2022 or (ii) the issuer's 2022 annual meeting of stockholders, subject to the reporting person's continued service on the board of directors.

Elevate your investments